📰 2 sources covering this story

Millions could gain easier access to popular peptides after FDA panel vote

First covered 6 hrs ago · latest take 2 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Millions could gain easier access to popular peptides after FDA panel vote
Fox News
Fox News2 hrs ago
Millions could gain easier access to popular peptides after FDA panel vote
An FDA panel voted to recommend six peptides including BPC-157, TB-500, and KPV for compounding by licensed pharmacies instead of grey market vendors.
STAT News
STAT News🏁 first to report6 hrs ago
STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives — contrary to company claims
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →